This study is designed to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy following oral administration of AZD3470 as a monot…

LymphomaNon-Hodgkin LymphomaHodgkin Lymphoma+4 more

~Estimated

~$10 – $7,500

AstraZenecaNCT06137144

Phase 1

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

This Phase I study will evaluate the safety of autologous Epstein-Barr virus-specific T lymphocytes modified to express a constitutively active IL7 receptor (C…

Diffuse Large B-Cell Lymphoma (DLBCL)Hodgkin LymphomaPeripheral T-cell Lymphoma (PTCL)+2 more

~Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT07729397